In the 1830s, Scottish surgeon Robert Liston was famed for his rapid amputations, crucial before the advent of anesthesia. This video traces the evolution of anesthetics from ancient…
A recent publication in Interventional Pain Medicine, authored by Rohan Jotwani, MD, MBA, of Brigham and Women’s Hospital, Harvard Medical School in Boston, MA, and colleagues, demonstrates the…
NEW YORK (Reuters Health) – Peridural analgesia administered during colorectal cancer resection and postoperatively is associated with improved long-term survival rates, researchers in Germany report. “The present results…
NEW YORK (Reuters Health) – Monitoring carbon dioxide levels in addition to standard pulse oximetry in patients undergoing propofol sedation during colonoscopy reduces the incidence of oxygen desaturation,…
NEW YORK (Reuters Health) – Paracervical block is effective in decreasing pain associated with first-trimester surgical abortion, suggest results of a randomized controlled trial conducted in Portland, Oregon.…
NEW YORK (Reuters Health) – For women with breast cancer metastatic to bone, treatment with zoledronic acid to reduce skeletal complications does not prolong progression-free survival or overall…
NEW YORK (Reuters Health) – A single dose of oral azithromycin reduces the recurrence of trichiasis for up to three years more so than a six-week regimen of…
NEW YORK (Reuters Health) – Among patients with early stage non-small-cell lung cancer, treatment with gemcitabine and cisplatin before radical surgery is associated with better survival than is…
NEW YORK (Reuters Health) – Bone loss in postmenopausal women taking adjuvant letrozole for early breast cancer can be prevented with administration of zoledronic acid, investigators report in…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
